MedXY News

EnglishTag

SAVR

9 · 20 / page

Ask MedXY AI

type 2 diabetes clinical trial heart failure immunotherapy obesity atrial fibrillation cardiovascular risk Cardiology biomarkers clinical trials Hypertension oncology critical care public health artificial intelligence Alzheimer's disease breast cancer diabetes cardiovascular disease type 1 diabetes nutrition chronic kidney disease

Latest news

Tag

Cardiologyaortic stenosislong-term outcomes

10-Year Randomized Outcomes of Transcatheter or Surgical Aortic Valve Replacement in Intermediate-Risk Aortic Stenosis: What PARTNER 2A Adds to the Long-Term TAVR Evidence Base

By MedXY|Jun 17, 2026

The PARTNER 2A 10-year data show higher mortality and reintervention with balloon-expandable SAPIEN XT TAVR versus surgery in intermediate-risk patients, driven mainly by transthoracic access. Contemporary 10-year SAPIEN 3 data, however, su

Cardiology

aortic stenosis

SAVR

TAVI Superiority in Women with Aortic Stenosis: New Evidence from the DEDICATE-DZHK6 Trial

By MedXY|Mar 17, 2026

A subgroup analysis of the DEDICATE-DZHK6 trial reveals that TAVI significantly reduces the 1-year risk of death or stroke compared to SAVR in both sexes, with particularly pronounced clinical benefits for women, especially regarding stroke

Cardiologyaortic stenosisSAVR

TAVI vs. SAVR in Women: RHEIA Trial Reveals Distinctive Echocardiographic Advantages for Both Approaches

By MedXY|Jan 22, 2026

The RHEIA trial substudy compares echocardiographic outcomes between TAVI and SAVR in women. While SAVR offers superior LVH regression and lower gradients, TAVI demonstrates significant benefits in preserving right ventricular function and

CardiologyBicuspid Aortic StenosisNOTION-2

TAVR vs. SAVR in Younger Low-Risk Patients: 3-Year NOTION-2 Insights Highlight Bicuspid Challenges

By MedXY|Jan 18, 2026

Three-year results from the NOTION-2 trial show comparable clinical outcomes between TAVR and SAVR in younger, low-risk patients. However, higher event rates in the bicuspid subgroup suggest a need for caution and individualized procedural

Cardiologyaortic stenosisSAVR

Surgical Aortic Valve Replacement Emits Twice the CO2 of TAVR: What This Means for Practice and Policy

By MedXY|Nov 29, 2025

A life cycle assessment found SAVR produces roughly double the carbon footprint of transcatheter aortic valve replacement (TAVR), with postoperative ICU and ward care as the main drivers. Results highlight opportunities to decarbonize cardi

Cardiologyaortic valve replacementcarbon footprint

Surgical aortic valve replacement produces about twice the carbon footprint of transcatheter approaches: clinical and stewardship implications

By MedXY|Nov 29, 2025

A life cycle assessment found SAVR emits ~620–750 kg CO2e per case—roughly double OR- or cath-lab TAVR (~280–360 kg CO2e). ICU length of stay and postoperative care were the dominant contributors, highlighting targets for low-carbon periope

Cardiologyaortic valve replacementlong-term outcomes

Long-Term Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement: A Meta-Analysis of Time-to-Event Data

By MedXY|Oct 12, 2025

This meta-analysis evaluates 5-year outcomes comparing TAVI and SAVR across risk profiles, revealing early advantages with TAVI that level off long-term, with no significant difference at 5 years.

Cardiologyaortic stenosisSAVR

Three-Year Outcomes of NOTION-2 Trial: Comparing TAVR and SAVR in Younger Low-Risk Patients with Tricuspid or Bicuspid Aortic Stenosis

By MedXY|Oct 6, 2025

The NOTION-2 trial demonstrates comparable three-year outcomes between TAVR and SAVR in low-risk patients aged 60-75 with severe tricuspid or bicuspid aortic stenosis, with low rates of valve deterioration and re-intervention.

Cardiologyaortic stenosisMeta-Analysis

TAVI vs SAVR at Low–Intermediate Risk: What the New Individual‑Patient Meta‑Analysis Means for Practice

By MedXY|Oct 5, 2025

A patient‑level meta‑analysis of randomized trials finds transcatheter aortic valve implantation (TAVI) reduces 1‑year risk of death or stroke versus surgical AVR in low– to intermediate‑risk patients—informing patient selection, heart‑team

Ask MedXY AI

Most popular

Critical Care

New A-TANGO Organ Failure Score Refines ACLF Diagnosis and Risk Stratification in Global Cohorts

Cardiology

MIND Diet Linked to Lower Cancer Risk and Reduced Mortality, With New Genetic Insights

Neurology

High-Intensity Resistance Training Improves Lower Limb Strength More Than Low-Moderate Intensity in Older Adults

Clinical Updates

Retatrutide in Type 2 Diabetes and MASLD: Integrative Evidence on Body Composition and Liver Fat Reduction

Family Medicine & Nutrition

The Curious Scent of Feces: The Dual Identity and Health Secrets of Skatole

MedXY News - SAVR